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Some patients with endobronchial tuberculosis (EBTB) have wheeze on physical examination and normal 
chest PA, which mimic bronchial asthma. Non-specific bronchial challenge tests have been used to confirm the 
presence of bronchial hyperreactivity, which is a hallmark of bronchial asthma. 
To evaluate the effect of endobronchial tuberculous inflammation on bronchial responsiveness to histamine, 
the provocation concentrations of histamine required to reduce FEV, by 20% of the pre-challenge baseline 
(PC,,) were compared between patients with EBTB, patients with symptomatic bronchial asthma and normal, 
healthy controls. PC,, in EBTB patients (17.2 I-t 2.3 mg ml - ‘) and normal controls (19.5 f 1.4 mg ml ~ ‘) were 
significantly higher than in bronchial asthma patients (0.99 & 0.15 mg ml - ‘). PC,, in EBTB patients was not 
affected by disease location in the bronchial tree and was not correlated with FVC or FEV,. 
In conclusion, one should consider the possibility of EBTB for differential diagnosis from bronchial asthma, 
if airway responsiveness appears normal in wheezy patients. 
Introduction 
With the development of anti-tuberculosis chemo- 
therapy, the incidence of tuberculosis had declined in 
the decades preceding the 1980s. However, endo- 
bronchial tuberculosis (EBTB) was observed in about 
20% of patients with pulmonary tuberculosis who 
underwent bronchoscopy (1). Some patients showed 
isolated endobronchial lesions without parenchymal 
tuberculosis (24). Recently, EBTB was reported in 
patients with AIDS (5). 
The main clinical manifestations of EBTB are 
cough and sputum. However, 15-57% of EBTB 
patients have a localized or diffuse wheezing on 
Airway hyperresponsiveness to non-specific 
stimuli, such as histamine and methacholine, is a 
characteristic feature in symptomatic patients with 
bronchial asthma, and has been used in diagnosis 
(7,s). There are no data on airway responsiveness in 
EBTB. If EBTB patients show different responsive- 
ness to bronchial provocation tests with histamine 
from bronchial asthma patients, non-specific bron- 
chial provocation tests can be used for differential 
diagnosis in wheezy patients. In this study, airway 
responsiveness to histamine in patients with EBTB 
was compared with that in symptomatic bronchial 
asthma patients and normal, healthy controls. 
physical examination (24), which mimics bronchial 
asthma (6). In cases of EBTB with clinical manifes- Methods 
tation of wheezing on physical examination and 
normal chest PA, differential diagnosis from bron- 
chial asthma is frequently difficult. Non-invasive 
methods such as the chest roentgenogram and flow- 
volume loops are insensitive for detection of stenosis 
in EBTB (2). The definite diagnosis of EBTB can be 
made by fiberoptic bronchoscopy (6). However, 
fiberoptic bronchoscopy is not recommended as 
a diagnostic tool in symptomatic patients with 
bronchial asthma. 
The study population were 15 patients with EBTB, 
62 patients with bronchial asthma, and 35 healthy 
controls. All subjects gave informed consent before 
participation. Wheezing was heard on the entire or 
localized lung field in all of the patients with EBTB 
and bronchial asthma. All patients with EBTB were 
initially suspected by the findings of chest CT, and 
diagnosed by the presence of caseating granuloma 
and/or acid-fast bacilli (AFB) on bronchoscopic 
biopsv specimens. Mvcobacterium tuberculosis was 
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infiltrations were observed in six patients and 
atelectasis was noted in two patients of EBTB. 
The diagnosis of bronchial asthma was based on 
the history of wheezing dyspnoea and documented by 
bronchodilator-induced improvement of FEV,, of 
more than 20%. Chest PA was normal in all patients 
with bronchial asthma. Healthy controls were 
included when they had no respiratory symptoms 
and a normal chest PA. FVC and FEV, were mea- 
sured with a computerized spirometer (Fukuda-300, 
Japan). The provocation concentration of histamine 
required to reduce the FEV, by 20% of the pre- 
challenge baseline (PC,,) was measured by 
Cockcroft’s method (9) using from 0.025 mg ml - ’ to 
25 mg ml- ’ of histamine. A dose-response slope was 
calculated as previously described (10). Bronchial 
provocation tests with histamine were performed, 
without medication for 24 h in bronchial asthma 
patients, and two days before the procedure of 
bronchoscopy in EBTB patients. 
The differences between groups were compared 
using the non-parametric Kruskal-Wallis H-test for 
continuous data. If found significant, the Mann- 
Whitney U-test with Bonferroni’s correction was 
applied to compare any two groups. The relation- 
ships between PC,, and physiologic parameters were 
studied using Spearman’s rank correlations. The dif- 
ference was considered significant when P was less 
than 0.05. The results were expressed as mean & SE, 
unless stated otherwise. 
Results 
FVC and FEV, were matched in EBTB and bron- 
chial asthma. FVC and FEV, were significantly lower 
in the patients with bronchial asthma and EBTB than 
normal controls. Age was matched between each 
group, however females predominated in the EBTB 
group (Table 1). All patients with EBTB had visible 
endobronchial lesions on bronchoscopy. The four 
types of EBTB were classified by bronchoscopic 
findings previously described (11). 
PC,, measured in EBTB patients ranged between 
1.89-25 mg ml - ’ with a geometric mean of 
17.2 f 2.3 mg ml - ’ histamine. In the symptomatic 
patients with bronchial asthma, PC,, ranged between 
0.025-5.14 mg ml- ’ histamine with a geometric 
mean of 0.99 * 0.15 mg ml - ’ histamine. PC,, of 
patients with EBTB was significantly higher than that 
of patients with bronchial asthma (P<O.Ol). The 
geometric mean of PC,, in EBTB patients was the 
same as that of normal controls (17.2 f 2.3 mg ml - ’ 
vs. 19.5 + 1.4 mg ml- ‘) (Fig. 1). All normal controls 
had PC,, greater than 5 mg ml- ’ histamine, 
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Fig. I Dose-response slope of histamine in normal con- 
trols, endobronchial tuberculosis (EBTB) patients and 
bronchial asthma (BA) patients. The value of the dose- 
response slope of the normal and EBTB groups was 
significantly lower than that of the BA group (P<O.Ol). 
Table I Clinical profiles of the study populations 
EBTB BA Normal control 
Number 15 62 35 
Mean age 37.3 + 3.0 40.2 zk 1.8 33.6 f 2.2 
(years) 
Age range 15-67 1 l-69 23-65 
(years) 
Sex (M:F) 3:12 28:34 25:15 
FVC (%)* 85.9 f 4.01- 86.6 l!z 1.4t 107.4 * 3.5 
FEV,(%)* 81.9 * 3.77 77.6 + 2.01 98.0 f 3.8 
SL 5.6 i 2.41 34.1 f 0.9 2.1 zk 0.6$ 
*percentage of predicted values (mean * SE); tP value less 
than 0.01 compared to those of healthy control; fP valve 
less than 0.01 compared to those of patients with bronchial 
asthma; SL, dose-response slope. 
except one case (4.8 mg ml ~ ’ histamine). Twelve of 
15 patients with EBTB had PC,, greater than 
5 mg ml - ’ histamine. However, all of the patients 
with symptomatic bronchial asthma, except one 
patient (5.14 mg ml ~ ’ histamine) had concentrations 
of PC,, lower than 5 mg ml - i histamine. The geo- 
metric mean of the dose-response slope of patients 
with EBTB was not significantly different from that 
of normal controls (5.6 + 2.5 ‘vs. 2.1 & 0.6) and 
was significantly lower than that of patients with 
bronchial asthma (34.1 * 0.9, PcO.01). 
All patients had visible lesions on bronchoscopy. 
The main locations of EBTB were the trachea and 
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Table 2 Physiologic parameters and bronchoscopic findings of patients with endobronchial 
tuberculosis 
Patient Location Bronchoscopy 
No. Sex FVC FEV, PC,, of EBTB Chest PA findings 
1 
2 
3 
4 
5 
6 
I 
8 
9 
10 
11 
12 
13 
14 
15 
M 68 61 20.8 
F 61 78 25 
F 127 117 4.55 
F 111 98 20 
F 115 112 25 
M 18 72 2.21 
F 73 69 13.8 
M 82 80 13.6 
F 84 86 1.89 
F 87 82 25 
F 56 50 25 
F 93 80 25 
F 67 65 25 
F 95 85 25 
F 88 97 20 
Trachea Infil Exudative 
Trachea Infil Ulcerative 
Trachea Clear Ulcerative 
Trachea Infil Exudative 
Trachea Infil Exudative 
Trachea Clear Exudative 
Lt main Clear Exudative 
Rt main Infil Cicatric 
Both main Clear Exudative 
Both main Clear Exudative 
Lt main Collapse Exudative 
Lt main Clear Exudative 
Rt main Clear Ulcerative 
Lobe Collapse Cicatric 
Lobe Collapse Exudative 
FVC and FEV, were expressed as predicted percentages, Lt, left; Rt, right, Main, main 
bronchus; Lobe, lobar bronchus; Infil, infiltration on chest PA. 
carina in six cases, the main and intermediate bronchi 
in seven cases and the lobar bronchus in two cases. 
Types of endobronchial lesions were composed of 
exudative (n= lo), ulcerative (n=3) and cicatricial 
stages (n=2). PC,, was not affected by location and 
type of EBTB. PC,, was also not correlated with 
FVC and FEV, in EBTB patients. After treatment 
with anti-tuberculous agents for 1 yr, four patients 
performed pulmonary function tests. Three of these 
patients showed improvement in FVC and FEV,, 
and the other patient showed minimal improvements. 
However, no change of PC,, was observed in these 
patients after treatment, when compared to those 
before treatment (Table 2). 
Discussion 
It was demonstrated that PC,, did not decrease in 
the patients with EBTB, compared with normal 
controls. PC,, values were also significantly greater 
in patients with EBTB and normal controls, than in 
patients with symptomatic bronchial asthma. This 
finding suggests that, in patients with cough and 
wheezing, one should consider the possibility of 
EBTB for differential diagnosis if airway responsive- 
ness is normal. PC,, has been used to confirm the 
presence of airway hyperreactivity, which is a hall- 
mark of bronchial asthma (8,9). Of course, patients 
with other lung diseases including hayfever, chronic 
bronchitis, emphysema and cystic fibrosis also show 
airway hyperresponsiveness to non-specific stimuli 
(1-v 
Airway responsiveness to non-specific stimuli may 
arise from bronchial inflammation (12,13). In bron- 
chial asthma, the airway inflammation was diffuse 
and characterized by epithelial detachment resulting 
in exposure of epithelial nerves (13). In contrast, 
airway inflammation was rather focal and limited in 
EBTB patients when compared with bronchial 
asthma patients. This focal and localized inflam- 
mation in EBTB patients does not seem to increase 
airway responsiveness to non-specific stimuli. There 
were some reports that bronchial hyperreactivity 
might be a manifestation of pulmonary sarcoidosis 
(14) and pulmonary tuberculosis (15) but the exact 
mechanism is not known. Some of the patients with 
pulmonary tuberculosis had low FVC and FEV,, and 
this might be related to bronchial hyperreactivity. 
In this study, most patients with EBTB did not 
have bronchial hyperreactivity, but a few cases had 
increased bronchial responsiveness. The FEV, values 
of these patients were above 80% of the predicted 
value, but the mechanism of increased bronchial 
hyperresponsiveness is not understood. It may, 
perhaps, be related to exposure of irritant receptors. 
The major inflammatory cells involved in bron- 
chial asthma and EBTB are very different: mast cells 
and eosinophils in bronchial asthma and lympho- 
cytes in EBTB. Of course, lymphocytes also partici- 
pate in airway inflammation of the asthmatic airway, 
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but their subtypes are different: type-2 helper cells in 
bronchial asthma (16) and type-l helper cells in 
EBTB (17). Although T-cell-dependent steps in a 
delayed-type hypersensitivity reaction were reported 
to be responsible for the induction of airway hyper- 
reactivity in mice (18) these cells might have no role 
in EBTB of humans. 
The patients selected for this study with bronchial 
asthma, had mild airflow limitation matched with 
physiologic derangements in EBTB patients. The 
calibre of the airway can influence the subsequent 
response to histamine (12). However, the lack of 
correlation between PC,, and FEV, or types of 
endobronchial lesion in the patients with EBTB 
suggest that airway narrowing is not a determi- 
nant for PC,, in EBTB. In this study, the ratio of 
female:male was higher in EBTB than in bronchial 
asthma and normal control groups. The predomi- 
nance of females in the EBTB group was reported in 
the other studies (3,4). As PC,, was not different 
between the male group and the female group of 
normal controls in this study (data not shown), 
sexual difference may not influence PC,, in EBTB. 
In conclusion, endobronchial tuberculous inflam- 
mation did not increase airway responsiveness. 
In wheezy patients, one should consider the possi- 
bility of EBTB for differential diagnosis if airway 
responsiveness is normal. 
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